Last reviewed · How we verify
NCT04793542: WITHME
Hot Water Immersion Therapy for Mental Health
NA trial testing lower-limb hot water immersion in Anxiety Disorders in 150 participants. Status unknown.
15 December 2022
Quick facts
| Lead sponsor | Lakehead University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 150 |
| Start date | 15 March 2021 |
| Primary completion | 15 December 2022 |
| Estimated completion | 15 March 2023 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- lower-limb hot water immersion
Conditions studied
- Anxiety Disorders — all drugs for Anxiety Disorders →
- Depression — all drugs for Depression →
- Post-traumatic Stress Disorder — all drugs for Post-traumatic Stress Disorder →
- Heat — all drugs for Heat →
Sponsor
Lakehead University
Who can join
18 and older, any sex, with Anxiety Disorders or Depression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In 2016, it was estimated that nearly 1 billion people worldwide were affected by a mental or addictive disorder, and were associated with considerable excess mortality. Acute heat therapy sessions (e.g. whole-body heating or foot immersions) have been shown to improve symptoms in individuals diagnosed with common mental health illness such as major depressive disorders and reduce anxiety. This study will assess the impact of an at-home 8-week lower-limb immersion in hot water on symptom severity in patients diagnosed with major depressive disorder, generalized anxiety disorder, and PTSD.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04793542
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Anxiety Disorders
Currently open trials in the same condition.
- NCT07340281 — Biomarkers for Exercise · NA · recruiting
- NCT07432945 — In Vivo Exposure vs. Videochat-Based Vicarious Exposure · NA · recruiting
- NCT07316374 — AI Chatbots for Anxiety Mental Health Literacy · NA · active not recruiting
- NCT07123467 — Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder · Phase 3 · recruiting
- NCT07174947 — SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depre · Phase 2 · recruiting
Other Lakehead University trials
Trials by the same sponsor.
- NCT06469762 — The Short-Term Effects of Dry Cupping the Lumbar Paraspinal Muscles in Individuals With Non-specific Low Back Pain · NA · completed
- NCT06584903 — Safe Indoor Temperature Limit for Fans · NA · completed
- NCT06154369 — JoyPop Mobile Mental Health App With Post-Secondary Students · NA · completed
- NCT05991154 — JoyPop Mobile Mental Health App With Indigenous Transitional-Aged Youth · NA · recruiting
- NCT06402929 — Honest, Open, Proud - College for Post-Secondary Students With Mental Health Challenges · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04793542 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lakehead University
- Last refreshed: 11 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04793542.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing